Brian Sun
Consigliere Generale presso TURG POIN
Posizioni attive di Brian Sun
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| TURG POIN | Consigliere Generale | 11/04/2022 | - |
Storia della carriera di Brian Sun
Precedenti posizioni note di Brian Sun
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SORRENTO THERAPEUTICS, INC. | Consigliere Generale | - | - |
| Segretario Aziendale | - | - |
Formazione di Brian Sun
| University of San Diego | Graduate Degree |
| The Johns Hopkins University | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| General Counsel | 2 |
| Graduate Degree | 2 |
| Corporate Secretary | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Brian Sun
- Esperienza
